Cytokine derived treatment with reduced vascular leak syndrome Grant US-11401312-B2 United States of America 02 Aug 2022
Method for treating rheumatoid arthritis by administering IL-6 receptor antibodies Grant US-11149089-B2 United States of America 19 Oct 2021
Complexes of IL-15 and IL-15Ralpha and uses thereof Grant US-11110150-B2 United States of America 07 Sep 2021
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia Grant US-11041008-B2 United States of America 22 Jun 2021
Pharmaceutical compositions comprising a polypeptide that binds to IL-6 Grant US-11008393-B2 United States of America 18 May 2021
Use of IL-15 to increase thymic output and to treat lymphopenia Grant US-10894816-B2 United States of America 19 Jan 2021
Methods for the treatment of interleukin-6 receptor-related diseases and disorders Grant US-10618966-B2 United States of America 14 Apr 2020
Compositions and methods for immunomodulation in an organism Grant US-10464993-B2 United States of America 05 Nov 2019
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells Grant US-10428133-B2 United States of America 01 Oct 2019
Methods for the preparation of compounds directed against interleukin-6 receptor (IL-6R) Grant US-10392440-B2 United States of America 27 Aug 2019
IL-15Ralpha sushi domain—IL-15 fusion proteins Grant US-10358477-B2 United States of America 23 Jul 2019
Complexes of IL-15 and IL-15Ralpha and uses thereof Grant US-10265382-B2 United States of America 23 Apr 2019
Methods for treating rheumatoid arthritis by administering interleukin-6 receptor… Grant US-10138302-B2 United States of America 27 Nov 2018
Methods for treating rheumatoid arthritis by administering IL-6 receptor antibodies Grant US-10118967-B2 United States of America 06 Nov 2018
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia Grant US-10093710-B2 United States of America 09 Oct 2018
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia Grant US-9975937-B2 United States of America 22 May 2018
Compositions and methods for immunomodulation in an organism Grant US-9969790-B2 United States of America 15 May 2018
Compositions and methods for immunomodulation in an organism Grant US-9932387-B2 United States of America 03 Apr 2018
Cell expressing complexes of IL-15 and IL-15Ralpha Grant US-9931377-B2 United States of America 03 Apr 2018
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells Grant US-9790261-B2 United States of America 17 Oct 2017
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells Grant US-9725492-B2 United States of America 08 Aug 2017
Methods for blocking or reducing binding of interleukin-6 to interleukin-6 receptor Grant US-9617341-B2 United States of America 11 Apr 2017
Nucleic acids that encode interleukin-6 receptor binding polypeptides Grant US-9605072-B2 United States of America 28 Mar 2017
Compositions and methods for immunomodulation in an organism Grant US-9371368-B2 United States of America 21 Jun 2016
Compositions and methods for Immunomodulation in an organism Grant US-9365630-B2 United States of America 14 Jun 2016
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells Grant US-9303080-B2 United States of America 05 Apr 2016
Methods of using IL-6R antibodies to block or reduce binding of IL-6 to IL-6R Grant US-9273150-B2 United States of America 01 Mar 2016
Nucleic acids encoding IL-6R-binding polypeptides Grant US-9181350-B2 United States of America 10 Nov 2015
Anti IL-6R polypeptides and compositions thereof Grant US-8962805-B2 United States of America 24 Feb 2015
Method for treating cancer by administering IL-15 and IL-15Ralpha complexes Grant US-8940288-B2 United States of America 27 Jan 2015
Use of IL-15 preparations to treat lymphopenia Grant US-8871191-B2 United States of America 28 Oct 2014
Anti-IL-6R polypeptides and pharmaceutical compositions thereof Grant US-8748581-B2 United States of America 10 Jun 2014
Compositions and methods for immunomodulation in an organism using IL-15 and soluble IL-15R… Grant US-8124084-B2 United States of America 28 Feb 2012